Finally, we demonstrate that the head and neck cancer cell line, SCC-104, which contains episomal HPV16 genomes, is hypersensitive to endothall, and treatment resulted in increased SAMHD1 and E2 recruitment to the replicating HPV16 genomes. The gene discussed is SAMHD1; the disease is head and neck cancer.